EUVIMEDEUVIMED entdecken
Crossref

Microfluidic Encapsulation of Exosomes Derived from Lipopolysaccharide‐Treated Mesenchymal Stem Cells in Hyaluronic Acid Methacryloyl to Restore Ovarian Function in Mice

Yifan Li, Hui Zhang, Changjun Cai, Jialian Mao, Ning Li, Danqing Huang, Shiyuan Li, Jun Yang, Jidong Zhou, Huan Wang, Yujuan Zhu, Lijun Ding iD und 1 weitere

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yifan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing Universit…. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian failure (POF) features an upward incidence nowadays, and the human umbilical cord mesenchymal stem cells (hUC‐MSCs)‐derived exosomes (MSC‐Exos) have shown applied values in the recovery of ovarian function. Here, a novel exosome‐encapsulated microcarrier prepared by microfluidic technology for ovarian repair after chemotherapy damage is presented. The exosomes derived from lipopolysaccharide (LPS)‐preconditioned hUC‐MSCs are encapsulated with hyaluronic acid methacryloyl (HAMA) via microfluidic electrospray, which is named HAMA/MSC‐Exos. Attributing to the biocompatibility and semipermeable property of HAMA, the encapsulated exosomes show great viability and controllable release behavior from HAMA. It is demonstrated that in situ transplantation of HAMA/MSC‐Exos can rescue ovarian functions of cyclophosphamide‐induced ovarian failure in mice by increasing ovarian volume, improving the number of antral follicles and restoring fertility. It is believed that the transplantation of HAMA/MSC‐Exos will provide a new concept for the treatment of POF in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMesenchymal Stem CellsHumansAnimalsMiceHyaluronic AcidLipopolysaccharidesMicrofluidics

Stichwörter der Autor:innen

exosomeshuman umbilical cord mesenchymal stem cellshyaluronic acid methacryloylmicrofluidicspremature ovarian failure

Substanzen

Hyaluronic AcidLipopolysaccharides

Autor:innen und Institutionen

  • Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
  • Center for Molecular Reproductive Medicine, Nanjing University, Nanjing, 210008, China.
  • School of Life Science and Technology, Southeast University, Nanjing, 210000, China.
  • Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China.
  • Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China.
  • Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.

ORCID-Profile: Lijun Ding

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, Y., Zhang, H., Cai, C., Mao, J., Li, N., Huang, D., Li, S., Yang, J., Zhou, J., Wang, H., Zhu, Y., Ding, L., & Sun, H. (2024). Microfluidic Encapsulation of Exosomes Derived from Lipopolysaccharide‐Treated Mesenchymal Stem Cells in Hyaluronic Acid Methacryloyl to Restore Ovarian Function in Mice. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303068

Vancouver

Li Y, Zhang H, Cai C, Mao J, Li N, Huang D, et al. Microfluidic Encapsulation of Exosomes Derived from Lipopolysaccharide‐Treated Mesenchymal Stem Cells in Hyaluronic Acid Methacryloyl to Restore Ovarian Function in Mice. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303068

BibTeX
@article{Li2024,
  author = {Li, Yifan and Zhang, Hui and Cai, Changjun and Mao, Jialian and Li, Ning and Huang, Danqing and Li, Shiyuan and Yang, Jun and Zhou, Jidong and Wang, Huan and Zhu, Yujuan and Ding, Lijun and Sun, Haixiang},
  title = {Microfluidic Encapsulation of Exosomes Derived from Lipopolysaccharide‐Treated Mesenchymal Stem Cells in Hyaluronic Acid Methacryloyl to Restore Ovarian Function in Mice},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303068}
}
Kostenlos starten →